Biovail Corp. International regulatory update

Biovail Corp. International (BVF) The FDA approved 100mg and 150mg doses of BVF's Oruvail (Ketoprofen) extended release nonsteroidal anti-inflammatory drug to treat osteoarthritis and rheumatoid arthr...